DK1092767T3 - Serinproteasespecifikke monoklonale antistoffer og anvendelse deraf - Google Patents
Serinproteasespecifikke monoklonale antistoffer og anvendelse derafInfo
- Publication number
- DK1092767T3 DK1092767T3 DK99926899T DK99926899T DK1092767T3 DK 1092767 T3 DK1092767 T3 DK 1092767T3 DK 99926899 T DK99926899 T DK 99926899T DK 99926899 T DK99926899 T DK 99926899T DK 1092767 T3 DK1092767 T3 DK 1092767T3
- Authority
- DK
- Denmark
- Prior art keywords
- neurosin
- monoclonal antibodies
- serine protease
- specific monoclonal
- strain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
- G01N2474/20—Immunohistochemistry assay
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18750698 | 1998-07-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1092767T3 true DK1092767T3 (da) | 2006-11-27 |
Family
ID=16207265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99926899T DK1092767T3 (da) | 1998-07-02 | 1999-07-02 | Serinproteasespecifikke monoklonale antistoffer og anvendelse deraf |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6645734B2 (da) |
| EP (1) | EP1092767B1 (da) |
| JP (1) | JP4369055B2 (da) |
| AT (1) | ATE342354T1 (da) |
| AU (1) | AU755340B2 (da) |
| CA (1) | CA2332131C (da) |
| DE (1) | DE69933565T2 (da) |
| DK (1) | DK1092767T3 (da) |
| ES (1) | ES2273496T3 (da) |
| PT (1) | PT1092767E (da) |
| WO (1) | WO2000001807A1 (da) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6569684B2 (en) | 2000-01-06 | 2003-05-27 | University Of Central Florida | Method of identifying and treating invasive carcinomas |
| CA2360219A1 (en) | 2000-10-27 | 2002-04-27 | Mount Sinai Hospital | Method for detecting alzheimer's disease |
| ATE365922T1 (de) * | 2000-10-27 | 2007-07-15 | Mount Sinai Hospital Corp | Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6) |
| US7666981B1 (en) | 2002-05-10 | 2010-02-23 | University Of Central Florida Research Foundation, Inc. | Inhibitors of prostasin |
| WO2003099328A1 (en) * | 2002-05-21 | 2003-12-04 | Mayo Foundation For Medical Education And Research | Methods and materials for treating inflammatory conditions |
| DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
| KR20080090408A (ko) | 2005-11-30 | 2008-10-08 | 아보트 러보러터리즈 | 항-Ａβ 글로불로머 항체, 이의 항원-결합 잔기, 상응하는하이브리도마, 핵산, 벡터, 숙주 세포, 당해 항체의 제조방법, 당해 항체를 포함하는 조성물, 당해 항체의 용도 및당해 항체의 사용 방법 |
| DK1976877T4 (da) | 2005-11-30 | 2017-01-16 | Abbvie Inc | Monoklonale antistoffer mod amyloid-beta-protein og anvendelser heraf |
| US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
| US20100311767A1 (en) | 2007-02-27 | 2010-12-09 | Abbott Gmbh & Co. Kg | Method for the treatment of amyloidoses |
| JP2010536932A (ja) * | 2007-08-30 | 2010-12-02 | ベンクト・オーゲルプ | 真菌感染を治療および予防するための、ニワトリ卵黄免疫グロブリン（ＩｇＹ）の局所投与 |
| WO2010151632A1 (en) * | 2009-06-25 | 2010-12-29 | Bristol-Myers Squibb Company | Protein purifacation by caprylic acid (octanoic acid ) precipitation |
| JP2013523182A (ja) | 2010-04-15 | 2013-06-17 | アボット・ラボラトリーズ | アミロイドベータ結合タンパク質 |
| CN105348387B (zh) | 2010-08-14 | 2020-08-25 | Abbvie 公司 | β淀粉样蛋白结合蛋白 |
| US10738078B2 (en) | 2014-11-03 | 2020-08-11 | Bristol-Myers Squibb Company | Use of caprylic acid precipitation for protein purification |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL105793A0 (en) * | 1992-05-28 | 1993-09-22 | Lilly Co Eli | Protease and related dna compounds |
| JPH09149790A (ja) * | 1995-09-29 | 1997-06-10 | Suntory Ltd | 新規セリンプロテアーゼ |
| AU4480797A (en) * | 1996-09-13 | 1998-04-02 | Dana-Farber Cancer Institute | Protease m, a novel serine protease |
-
1999
- 1999-07-02 WO PCT/JP1999/003578 patent/WO2000001807A1/ja active IP Right Grant
- 1999-07-02 CA CA002332131A patent/CA2332131C/en not_active Expired - Fee Related
- 1999-07-02 AT AT99926899T patent/ATE342354T1/de active
- 1999-07-02 EP EP99926899A patent/EP1092767B1/en not_active Expired - Lifetime
- 1999-07-02 ES ES99926899T patent/ES2273496T3/es not_active Expired - Lifetime
- 1999-07-02 AU AU43966/99A patent/AU755340B2/en not_active Ceased
- 1999-07-02 DE DE69933565T patent/DE69933565T2/de not_active Expired - Lifetime
- 1999-07-02 PT PT99926899T patent/PT1092767E/pt unknown
- 1999-07-02 JP JP2000558197A patent/JP4369055B2/ja not_active Expired - Fee Related
- 1999-07-02 DK DK99926899T patent/DK1092767T3/da active
-
2000
- 2000-12-21 US US09/741,171 patent/US6645734B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2332131A1 (en) | 2000-01-13 |
| DE69933565D1 (de) | 2006-11-23 |
| DE69933565T2 (de) | 2007-07-05 |
| US6645734B2 (en) | 2003-11-11 |
| PT1092767E (pt) | 2007-01-31 |
| AU4396699A (en) | 2000-01-24 |
| US20010016331A1 (en) | 2001-08-23 |
| AU755340B2 (en) | 2002-12-12 |
| EP1092767A1 (en) | 2001-04-18 |
| EP1092767B1 (en) | 2006-10-11 |
| ES2273496T3 (es) | 2007-05-01 |
| WO2000001807A1 (fr) | 2000-01-13 |
| JP4369055B2 (ja) | 2009-11-18 |
| ATE342354T1 (de) | 2006-11-15 |
| CA2332131C (en) | 2007-05-15 |
| EP1092767A4 (en) | 2001-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1092767T3 (da) | Serinproteasespecifikke monoklonale antistoffer og anvendelse deraf | |
| ATE488576T1 (de) | Schnellproduktion monoklonaler antikörper | |
| AU577745B2 (en) | Somatic human hybridoma fusion partner for the production of human monoclonal antibodies | |
| ATE295376T1 (de) | Monoklonaler antikörper als hemmstoff für gm-csf, il-3, il-5 und andere zytokine und deren verwendung | |
| DK1881064T3 (da) | HCV-anti-kerne monoklonalt antistof | |
| ATE440868T1 (de) | Monoklonaler antikírper gegen ein prion protein und dessen verwendung zum nachweis von prionen | |
| DK1562972T3 (da) | Modifikation af FcRn-bindingsaffiniteter eller serumhalveringstider for antistoffer ved mutagenese | |
| DK1654286T3 (da) | Humaniseret anti-CD4-antistof med immunsuppressive egenskaber | |
| DK1167537T3 (da) | Fremgangsmåde til fremstilling af et monoklonalt antistof | |
| LT2005099A (en) | Antibodies directed to monoclonal chemo-atractant protein-1 (mcp-1) and uses thereof | |
| EP0176355A3 (en) | Antigen-independent immunoassay system | |
| ATE324381T1 (de) | Mutiertes scfv-fragment des okt-3 antikörpers | |
| DE60014124D1 (de) | Antikörper, die spezifisch für fullerene sind | |
| CY1107858T1 (el) | Ccr5 αντισωματα pa14 | |
| WO2004106385A3 (en) | Monoclonal antibodies specific for buprenorphine and metabolites thereof | |
| EP0102228A3 (en) | Hybridoma secreting a monoclonal antibody specific for 5-bromo and 5-iododeoxyuridine and reagent for measuring cellular proliferation | |
| DK0709455T3 (da) | Monoklonalt antistof med humanglicentin, hybridoma til fremstilling af antistoffet og assaymetode for humanglicentin ved an | |
| SI1396501T1 (sl) | Protitelesa za identifikacijo in/ali izolacijo najmanj ene celiäśne populacije, ki je izbrana iz skupine, ki obsega hematopoetske matiäśne celice, nevronske matiäśne celice, nevronske prekurzorske celice, mezenhimske matiäśne celice in mezenhimske pr | |
| DE69224134T2 (de) | Monoklonale Antikörper gegen Hepatitis-C-Virus | |
| DE602005025414D1 (de) | Immunnachweiskit in verbindung mit neuroglobin-enzym sowie verwendung davon | |
| DK1161522T3 (da) | Fremgangsmåde til isolering af CD8+-celler og beslægtede hybridomaceller, antistoffer og polypeptider | |
| WO2005003379A3 (fr) | Procede automatise de criblage a grande echelle de cellules secretant des anticorps monoclonaux | |
| RU2005115525A (ru) | Штамм культивируемых клеток мышиной гибридомы а3, используемый для получения моноклональных антител к антигену ядрышек клеток человека |